Literature DB >> 19939300

Connexin-26 mutations in deafness and skin disease.

Jack R Lee1, Thomas W White.   

Abstract

Gap junctions allow the exchange of ions and small molecules between adjacent cells through intercellular channels formed by connexin proteins, which can also form functional hemichannels in nonjunctional membranes. Mutations in connexin genes cause a variety of human diseases. For example, mutations in GJB2, the gene encoding connexin-26 (Cx26), are not only a major cause of nonsyndromic deafness, but also cause syndromic deafness associated with skin disorders such as palmoplantar keratoderma, keratitis-ichthyosis deafness syndrome, Vohwinkel syndrome, hystrix-ichthyosis deafness syndrome and Bart-Pumphrey syndrome. The most common mutation in the Cx26 gene linked to nonsyndromic deafness is 35DeltaG, a frameshift mutation leading to an early stop codon. The large number of deaf individuals homozygous for 35DeltaG do not develop skin disease. Similarly, there is abundant experimental evidence to suggest that other Cx26 loss-of-function mutations cause deafness, but not skin disease. By contrast, Cx26 mutations that cause both skin diseases and deafness are all single amino acid changes. Since nonsyndromic deafness is predominantly a loss-of-function disorder, it follows that the syndromic mutants must show an alteration, or gain, of function to cause skin disease. Here, we summarise the functional consequences and clinical phenotypes resulting from Cx26 mutations that cause deafness and skin disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19939300     DOI: 10.1017/S1462399409001276

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  55 in total

Review 1.  Pathological hemichannels associated with human Cx26 mutations causing Keratitis-Ichthyosis-Deafness syndrome.

Authors:  Noah A Levit; Gulistan Mese; Mena-George R Basaly; Thomas W White
Journal:  Biochim Biophys Acta       Date:  2011-09-10

2.  Charge at the 46th residue of connexin 50 is crucial for the gap-junctional unitary conductance and transjunctional voltage-dependent gating.

Authors:  Xiaoling Tong; Hiroshi Aoyama; Tomitake Tsukihara; Donglin Bai
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

3.  Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.

Authors:  Eric R Press; Qing Shao; John J Kelly; Katrina Chin; Anton Alaga; Dale W Laird
Journal:  J Biol Chem       Date:  2017-04-20       Impact factor: 5.157

4.  Lower carrier rate of GJB2 W24X ancestral Indian mutation in Roma samples from Hungary: implication for public health intervention.

Authors:  Csilla Sipeky; Petra Matyas; Marton Melegh; Ingrid Janicsek; Renata Szalai; Istvan Szabo; Reka Varnai; Greta Tarlos; Alma Ganczer; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

Review 5.  Connexin hemichannels and cochlear function.

Authors:  Vytas K Verselis
Journal:  Neurosci Lett       Date:  2017-09-14       Impact factor: 3.046

Review 6.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

7.  Altered inhibition of Cx26 hemichannels by pH and Zn2+ in the A40V mutation associated with keratitis-ichthyosis-deafness syndrome.

Authors:  Helmuth A Sanchez; Rick Bienkowski; Nefeli Slavi; Miduturu Srinivas; Vytas K Verselis
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

8.  Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome.

Authors:  Helmuth A Sánchez; Gülistan Mese; Miduturu Srinivas; Thomas W White; Vytas K Verselis
Journal:  J Gen Physiol       Date:  2010-07       Impact factor: 4.086

9.  The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.

Authors:  Pallavi V Mhaske; Noah A Levit; Leping Li; Hong-Zhan Wang; Jack R Lee; Zunaira Shuja; Peter R Brink; Thomas W White
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-27       Impact factor: 4.249

Review 10.  Connexin channel modulators and their mechanisms of action.

Authors:  Vytas K Verselis; Miduturu Srinivas
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.